News Feed

CCL introduces first ever ticagrelor in Pakistan

LAHORE, JULY 2018: CCL Pharmaceuticals recently launched the first ever ticagrelor in Pakistan in a ceremony held in a local hotel in Lahore. Ticagrelor is an FDA approved antiplatelet therapy to reduce blood clot formation, which significantly reduces cardiovascular events and deaths in heart attack survivors. Cardiac patients receiving antiplatelet therapy have a new option with the launch ...

Read more